Alix Marduel Corcept Therapeutics Inc

As of November 13, 2008


Alix Marduel Net Worth

  • Net worth is estimated to be at least $84.23M
  • Owns at least 166,491 units of Corcept Therapeutics Inc stock

Alix Marduel Trading

  • Largest purchase of shares was 1,059,135 units , worth over $2.93M on March 26, 2008
  • In total has made about 7 transactions over 4 years
  • Usually trades in August and April, with the busiest year in 2007

ALTA BIOPHARMA PARTNERS II LP, ALIX MARDUEL, JEAN DELEAGE, FARAH CHAMPSI, ALTA BIOPHARMA MANAGEMENT II LLC, ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC, ALTA PARTNERS II INC

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Alix Marduel Mailing Address

  • Mailing address is One Embarcadero Center Suite 3700 San Francisco CA 94111 CA

Corcept Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Joseph K. Belanoff, M.D., 2020 $769,567 $744,000 $4,237,643 $10,892 $5,762,102
Joseph K. Belanoff, M.D., 2019 $707,525 $745,290 $3,506,155 $ $4,958,970
Joseph K. Belanoff, M.D., 2018 $679,792 $477,750 $5,157,075 $ $6,314,617
Andreas Grauer, M.D., 2020 $454,550 $219,157 $1,271,293 $118,274 $2,063,274
Andreas Grauer, M.D., 2019 $362,267 $243,720 $3,115,335 $78,245 $3,799,567
Hazel Hunt, Ph.D., 2020 $431,873 $243,000 $2,084,640 $ $2,759,513
Sean Maduck, 2020 $474,380 $214,157 $2,508,404 $ $3,196,941
Sean Maduck, 2019 $456,133 $308,881 $1,476,276 $ $2,241,290
Sean Maduck, 2018 $436,667 $198,000 $2,171,400 $ $2,806,067
Charles Robb, 2020 $474,380 $321,236 $2,118,822 $ $2,914,438
Charles Robb, 2019 $456,133 $308,881 $1,845,345 $ $2,610,359
Charles Robb, 2018 $436,667 $237,600 $2,171,400 $ $2,845,667
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm

Corcept Therapeutics Inc Insider Trading

  • The most recent transaction was 35,000 units sold on May 19, 2022 by Gary Charles worth over $684.4K
  • In the last 18 years, insiders at Corcept Therapeutics Inc sold an estimated value of $163.14M and bought an estimated value of $183.48M
  • The most active traders are Joseph K Belanoff, Chief Executive Officer,  Robert Roe, President and Secretary,  and Leonard Baker Jr, Director
  • Insider trading is most common in February, with the busiest year in 2006

CORCEPT THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1